Newsletter

Alzheimer's disease
Will hundreds of experiments and trials be able to solve the labyrinths of Alzheimer's disease?
Alzheimer's disease

More Whitepapers / Newsletters

Progressive Supranuclear Palsy (PSP)
Progressive Supranuclear Palsy...

Progressive Supranuclear Palsy (PSP) is a rare progressive disorder resulting from damage that occurs in brain cells over time. It causes problems with balance, speech, swallowing, movement, and visio...

Lean Management
Lean Management: Following the...

Lean is a multi-faceted framework that allows organisations to exercise different initiatives simultaneously in many dimensions; some consider effective execution either by achieving major strategic c...

Remdesivir In COVID-19
Remdesivir In COVID-19

Remdesivir is a broad-spectrum antiviral drug that has previously demonstrated in vitro and in vivo activity against the viral pathogens MERS and SARS, which are also coronaviruses having structural s...

Digital Health Transformation: 2020 Roadmap For Innovation Whitepaper
Digital Health Transformation:...

The Digital Era has officially hit Prime Time. Currently, the potentiality to digitally transform a patient's healthcare service experience is becoming a significant competitive parameter for organiza...

Hospital-Acquired Bacterial Pneumonia/ Ventilator-Associated Bacterial Pneumonia
Hospital-Acquired Bacterial Pn...

Hospital-acquired bacterial pneumonia (HABP) is the most common type of health-care-associated infections (HAIs) and hospital-acquired infections. It is often seen in patients admitted to ICU wards. A...